Hill & Smith Full Year 2024 Earnings: Misses Expectations

Hill & Smith (LON:HILS) Full Year 2024 Results

Key Financial Results

• Revenue: UK£855.1m (up 3.0% from FY 2023).
• Net income: UK£76.4m (up 11% from FY 2023).
• Profit margin: 8.9% (up from 8.3% in FY 2023). The increase in margin was driven by higher revenue.
• EPS: UK£0.95 (up from UK£0.86 in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Hill & Smith Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) also missed analyst estimates by 13%.

The primary driver behind last 12 months revenue was the Engineered Solutions segment contributing a total revenue of UK£418.7m (49% of total revenue). Notably, cost of sales worth UK£513.3m amounted to 60% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to UK£185.1m (70% of total expenses). Explore how HILS's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Metals and Mining industry in the United Kingdom.

Performance of the British Metals and Mining industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

You should learn about the 1 warning sign we've spotted with Hill & Smith.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.